Abstract: Vitamin C is an essential human nutrient obtained primarily from plant foods. Despite the necessity of the vitamin for human health and the essential role that it plays in plant stress resistance, it is only in the last decade that an understanding of its biosynthesis in plants has emerged. These fundamental discoveries present for the first time the opportunity to manipulate crop plants for improved human nutrition and enhanced agronomic performance and are discussed in relation to recent patents protecting aspects of vitamin C synthesis and degradation in plants.
INTRODUCTION
Vitamin C (L-ascorbic acid; AsA) is a powerful antioxidant and essential human nutrient that has extensive industrial and medicinal applications resulting in global requirements estimated at 154 thousand tons in 2007 [1] . Approximately 50% is used in the food industry where it is added during processing to prevent pigment discolouration and enzymatic browning, prevent loss of flavour and aroma, protect or enhance nutrient content and extend shelf-life [2] . A further 30% is used in the pharmaceutical industry for both medical applications and the production of vitamin supplements. The remainder is used in animal feeds (13%), the cosmetic industry (5%) and other industrial processes (2%) [1] .
The commercial value of AsA manufacture was recognised in the early part of the 20 th century and industrial processes have been heavily patented since the 1930's. Tadeus Reichstein first patented the synthesis of AsA from L-xylosone in 1935 [3] however difficulties in obtaining the starting material prevented the full commercial application of this process. In the same year a second patent was published demonstrating a method for the manufacture of AsA from 2-keto-L-gulonic acid [4] for which a facile method of production from the readily available L-sorbose had already been developed [5] . Further process improvements were introduced by Walter Haworth and colleagues who proposed the synthesis of L-sorbose from sorbitol by microbial fermentation [6] . This series of reactions formed the basis of the Reichstein process which dominated global AsA manufacture for over 60 years [7] Fig. (1) .
in 2007 [8] . In part to overcome the threat represented by Chinese competition, there has been significant recent investment into research and development by European, American and Asian manufacturers resulting in a resurgence in AsA patent activity in recent years. Additional drivers for research have included scientific advances made in the areas of plant AsA biosynthesis and an appreciation of the metabolic flexibility of the yeast D-erythroascorbic acid pathway.
Vitamin C is an essential part of the diet, with the vast majority coming from plant foods and efforts to understand its biosynthesis in plants stretch back to the 1950's. Despite the pioneering efforts of Frank Loewus and colleagues, it wasn't until 1998 that a pathway compatible with all of the available scientific knowledge was finally published [9] and since then various other pathways have been proposed. Manipulation of expression of genes encoding biosynthetic enzymes from all of the proposed pathways have been demonstrated to impact on plant AsA levels. These novel discoveries have inevitably led to significant new patent activity.
The present review summarises the latest scientific research regarding the improvement of crop quality with respect to its AsA content and the latest developments in microbial fermentations for the industrial synthesis of AsA. The application of this work is highlighted by reference to recent patents in the field. Despite the fact that China now supplies more than 80% of vitamin C worldwide [8] , very little information is available regarding the latest scientific and industrial developments hence the review focuses on work undertaken in the USA and Europe. Previous reviews have covered the scientific literature regarding the industrial and biological manufacture of vitamin C [7, 10, 11] and recent advances in understanding and manipulating plant vitamin C biosynthesis [12] [13] [14] .
SYNTHESIS OF VITAMIN C IN PLANTS -EMER-GING OPPORTUNITIES FOR THE IMPROVEMENT OF CROP AGRONOMY AND HUMAN NUTRITION
The last decade has seen rapid advances in understanding AsA biosynthesis and metabolism in plants and the commercial potential of these discoveries are reflected in the flurry of patent activity since the turn of the millennium. Claims primarily focus on the development of crops with improved agronomic and nutritional qualities although the significance of the discoveries for the biological manufacture of vitamin C has not been overlooked.
Despite the importance of vitamin C in human nutrition and plant physiology, it wasn't until 1998 that a widely accepted biosynthetic pathway that reconciled apparently conflicting previous data was presented [9] . A series of alternative pathways were subsequently proposed based on novel biochemical and molecular data and the engineering of pathways in transgenic plants [15] [16] [17] . As a result four potential routes to vitamin C have been described in plants within the last decade Fig. (2) . Significant debate continues regarding the physiological significance of the different pathways, recently enlivened by the observation that mutation of the two genes encoding an enzyme specific to the L-galactose (L-Gal) biosynthetic pathway Fig. (2) is lethal in Arabidopsis seedlings [18] . Despite these discussions, the biotechnological potential of the alternative pathways has clearly been demonstrated and upregulation of genes encoding biosynthetic enzymes within the postulated pathways has resulted in enhanced plant AsA content. Scientific activity has also been strong regarding the metabolism and degradation of AsA [19, 20] and the manipulation of catabolic pathways represents an alternative prospect for engineering plant AsA content [21] .
It has been known for many years that the final step of AsA biosynthesis in plants is the oxidation of Lgalactonolactone (L-GalL) by the mitochondrial enzyme LGalL dehydrogenase (E.C. 1.3.2.3) [22] . Early work also showed that the vitamin C content of cress seedlings was enhanced following supply of D-galacturonic acid (D-GalUA) methyl ester and so a biosynthetic pathway was proposed in which D-galactose (D-Gal) was oxidised to D-GalUA then further metabolised to AsA via the intermediate L-GalL [23] .
The implication of such a pathway was that the carbon skeleton of D-Gal would be inverted during the synthesis of AsA so that C1 of D-Gal would become C6 of AsA. This hypothesis was challenged following the supply of plant tissues with specifically labelled precursors which suggested that in fact, there was no inversion of the carbon skeleton when AsA was synthesised from sugars [24] . A later molecular analysis suggested that AsA could be synthesised from D-GalUA in strawberry fruit but that the source of DGalUA was not D-Gal directly but uronic acids released from pectin depolymerisation [15] (D-GalUA pathway, Fig. (2) ). A number of potential pathways were proposed that would be compatible with the data showing a lack of carbon chain inversion from sugars including one using the intermediates D-glucosone and L-sorbosone [25] , the latter compound being an important precursor in industrial microbial fermentations today. Despite these efforts, it took over 40 years' investigation until a pathway consistent with all of the available biochemical evidence was proposed [9] [L-Gal pathway, Fig. (2) ]. The principal advances leading to the discovery of the pathway were the observation that L-Gal was as effective an AsA precursor as L-GalL and the demonstration of enzymatic synthesis of free L-Gal from GDP-L-Gal in plant extracts. GDP-L-Gal itself was synthesised from GDP-D-mannose (GDP-D-Man) by the previously identified enzyme GDP-D-Man 3,5-epimerase (E.C. 5.1.3.18). The novel enzyme L-Gal dehydrogenase, responsible for the synthesis of L-GalL, was purified and N-terminal sequenced by Edman degradation and the identification of this sequence formed the basis of a patent protecting the biotechnological use of the pathway [26] . Subsequently, the gene encoding LGal dehydrogenase was cloned [27] and the utilisation of the full length protein or homologs and recombinant DNA encoding the protein were protected [28] . Several claims were made regarding both the utilisation of L-Gal dehydrogenase and the utilisation of knowledge regarding the proposed biosynthetic pathway. In particular the patents sought to protect organisms engineered to express L-Gal dehydrogenase with particular reference to those organisms that contained enhanced levels of AsA as a result of expressing the enzyme. A subsequent patent, outlined below, in which yeast were engineered to express plant GDP-D-mannose 3,5-epimerase, myo-inositol-1-phosphate phosphatase and L-Gal dehydrogenase permitting the synthesis of AsA in yeasts [29] could therefore be considered an infringement. Another novel aspect that was protected under the L-Gal dehydrogenase patent was the development of herbicides targeting this enzyme [28] . Given the fact that AsA is essential for plants as well as animals and the divergence in AsA biosynthetic pathways between plant and animal kingdoms it was predicted that such herbicides would be lethal to plants but harmless to animals.
Following identification of the primary AsA biosynthetic pathway in plants, several groups set to work purifying proposed biosynthetic enzymes. A key enzyme was GDP-DMan 3,5-epimerase responsible for the channelling of sugars into AsA biosynthesis. Although the enzyme activity had previously been identified in plant and algal extracts [30] , it had not been purified beyond 18-fold [31] until Beata Wolucka and colleagues purified the Arabidopsis enzyme sufficiently to allow peptide fingerprinting by mass spectrometry in 2001 [32] . This allowed identification of the full amino acid sequence in bioinformatic databases and subsequently a full length functional gene was cloned and expressed in Escherichia coli [17] . The utility of the isolated enzyme and associated gene sequence was recognised and the generation of any of the downstream AsA pathway
or AsA itself was protected either in vitro or in prokaryotic or eukaryotic cells [33] . In addition, the use of the recombinant enzyme for the development of antibodies was protected. Finally, high external mannose concentrations are highly toxic to plant cells. Mannose is taken up and rapidly phosphorylated, however most plant tissues have only a limited capacity for further metabolism of mannose phosphates resulting in sequestration of the inorganic phosphate pool [34] . It was proposed that one of the rate limiting enzymes for mannose phosphate metabolism was GDP-DMan 3,5-epimerase and therefore the use of the enzyme as a selectable marker in transgenic cells was also protected [33] .
Subsequent kinetic analysis of both the recombinant and native forms of GDP-D-Man 3,5-epimerase revealed that in addition to performing the double epimerisation of mannose to produce GDP-L-Gal, the enzyme was also capable of releasing the substrate following epimerisation at only the 5-position to form GDP-L-gulose (GDP-L-Gul). Furthermore, Arabidopsis suspension cells were capable of synthesising AsA when supplied with either L-Gul or L-GulL at rates similar to when supplied with the equivalent L-Gal derivatives [17] . It was therefore proposed that GDP-D-Man 3,5-epimerase was a dual function enzyme producing activated [9] . Subsequent kinetic analysis of the enzyme GDP-D-mannose 3,5-epimerase revealed that the reaction products were not limited to GDP-L-galactose but that GDP-L-gulose could also be formed. This data combined with other biochemical analyses led to the proposal that the true AsA biosynthetic pathway was via L-gulose [17] . In addition to the de novo pathways, a salvage pathway utilising galacturonic acid units recovered from pectin degradation was proposed in ripening strawberry fruit [15] and a further pathway utilising myo-inositol (released from phytate hydrolysis) has been described in Arabidopsis [16, 44] . Oxidation of AsA leads to the formation of dehydroascorbic acid which may either be recycled back to AsA via the ascorbate-glutathione cycle [12] or other reductive mechanisms. Alternatively dehydroascorbate can undergo C2/C3 cleavage to form oxalate and threonate [20] or C4/C5 cleavage to form tartrate and a C2 fragment [19] . Solid arrows represent single steps, dashed arrows represent multiple steps. . The use of the L-Gul pathway for synthesising vitamin C was therefore subsequently protected in the USA [35] .
Early in the new millennium, molecular analyses of strawberry fruit ripening reignited interest in the AsA biosynthetic pathway utilising D-GalUA as an intermediate. Although labelling studies carried out in the 1950's and 60's had provided evidence that the major AsA biosynthetic pathway in plants did not require inversion of the carbon skeleton from sugars, it was known that there was inversion of the carbon skeleton when AsA was synthesised from D-[1-14 C]GalUA in strawberry fruit [24] . This suggested the presence of an alternative biosynthetic route in which DGalUA, salvaged from pectin breakdown, was reduced to LGalL prior to conversion to AsA [D-GalUA pathway, Fig.  ( 2)]. Furthermore, evidence for a soluble enzyme activity in pea that was capable of the conversion of esters of D-GalUA to L-GalL had previously been presented [36] . Although the pathway remained a scientific curiosity, no further progress was made until 2003 when the gene encoding D-GalUA reductase was identified following an analysis of gene expression during strawberry fruit development. A transcript homologous to aldo-keto reductases was correlated with AsA accumulation and positive identification of the gene product as D-GalUA reductase was achieved following heterologous expression in Arabidopsis thaliana and enzymatic assay of crude protein extracts [15] . In the same lines where the enzyme was overexpressed there was also up to threefold increases in plant AsA concentration demonstrating the utility of the enzyme for improving plant nutritional quality [37] . The use of the protein and/or DNA construct to produce L-GalL from D-GalUA, to produce plants with high levels of AsA for human consumption or for producing plants with increased oxidative stress resistance was protected. It should however be recognised that recent research has suggested the relationship between plant vitamin C levels and agronomic performance is not simply positively correlated as was once expected. For example, while the Arabidopsis thaliana vtc mutants which contain reduced levels of AsA are more susceptible to ozone damage [38] , salt stress [39] and high light [40] they are more resistant to disease [41] . Conversely, work in our laboratory has shown that potato leaves containing high AsA levels allow more rapid aphid reproduction than those containing lower AsA levels (Vivera et al. unpublished). One mechanism for overcoming the potentially adverse physiological effects of manipulating plant AsA might be to limit AsA accumulation to specific organs such as tubers or fruits. This could be achieved via tissue specific gene expression or alternatively by manipulating the transport of AsA from source to sink tissues. The recent finding that symplastic phloem loaders appear to specifically tag AsA for transport may represent a mechanism by which such manipulation could be achieved [42] .
A third alternative pathway was proposed that had similarities to the animal biosynthetic pathway. Where the pathway diverges from the animal pathway is in the synthesis of D-glucuronic acid (D-GlcUA) which is via myoinositol in plants [myo-inositol pathway, Fig. (2) ] but from phosphorylated intermediates in animals. It had been known for some time that L-gulonolactone (L-GulL) was a suitable AsA precursor when supplied to plant tissues [23] and a route to L-GulL had been proposed from myo-inositol via Dglucuronic acid (D-GlcUA) [43] . Evidence to suggest that such a pathway may operate in vivo was obtained following the analysis of homozygous Arabidopsis lines overexpressing an endogenous myo-inositol oxygenase (E.C. 1.13.99.1) responsible for oxidising myo-inositol to DGlcUA. In the overexpressing lines foliar AsA levels were 2-3 fold higher than wild-type plants [16] . Further evidence to support the pathway came from the observation that increased conversion of phytate (inositol hexakisphosphate) to free myo-inositol could also enhance foliar AsA concentrations [44] . Arabidopsis mutants in which a phytase (inositol phosphate phosphatase) was upregulated by activation tagging showed two fold increased foliar AsA levels compared to wild-type plants. Similarly, plants expressing the gene under the control of the 35S constitutive promoter showed a 2-fold increase in foliar AsA. On the contrary insertion mutants in which the gene was deactivated had a 30% decrease in foliar AsA levels.
Unexpectedly, enhancing plant AsA levels via overexpression of myo-inositol oxygenase also improved the rate of accumulation of biomass in both Arabidopsis and lettuce [45] . Similarly, the overexpression of other genes encoding enzymes from the same pathway (gulonolactone oxidase and D-GlcUA reductase) enhanced biomass accumulation and AsA content. Those plants that had increased AsA levels also showed improved performance under salt stress compared to wild-type plants. These findings were included in a patent protecting the utility of upregulation of plant AsA content for increasing plant growth, biomass and stress tolerance [45] . It was envisaged that such applications would be useful for increasing food production for a growing population and because both aerial and below ground biomass was enhanced for improving carbon sequestration.
An alternative approach to the manipulation of plant AsA levels is modulation of recycling and degradation as illustrated by patents taken out by groups from the USA [46] and Australia [21] . The former approach was taken by Daniel Gallie and colleagues who manipulated the expression of the key recycling gene dehydroascorbate reductase (E.C. 1.8.5.1) in both tobacco and maize [47] . Gene expression levels were enhanced up to 100-fold with a similar increase in soluble enzyme activity resulting in up to 4-fold increases in AsA content of aerial tissues. The utility of manipulating dehydroascorbate reductase activity to control levels of AsA in plants was patented [46] . Further work in the authors' laboratory demonstrated a clear relationship between guard cell hydrogen peroxide levels, AsA redox state and the control of guard cell aperture [48] . It was therefore proposed that manipulation of foliar AsA content and redox state could be used to i) protect the plant from drought and aerosolised toxins by reducing the AsA content and inducing stomatal closure or ii) improve the carbon fixation activity of the plant by enhancing foliar AsA resulting in stomatal opening facilitating gas exchange with the atmosphere.
A second method for manipulating plant AsA content by altering AsA degradation focussed on the C4/C5 cleavage pathway Fig. (2) . Pioneering work in the 1970's and 80's had demonstrated the pathway intermediates as 2-keto-Lgulonate, L-idonate and 5-keto-D-gluconate [49] however the enzymes responsible for pathway catalysis had remained elusive, in part due to the difficulty in extracting and purifying active enzymes from fruit tissues. The problems were overcome following the application of transcriptional analysis to grape tissues actively accumulating tartrate. A candidate list of 87 genes showing transcriptional profiles correlating with tartrate accumulation was interrogated for those showing homology to oxido-reductases [19] . This was further refined by analysis of gene expression in Vitaceae fruit that accumulated different levels of tartrate. In particular one species (Ampelopsis aconitifolia) where tartrate could not be detected one of the candidate genes was not expressed and it was confirmed as encoding an L-idonate dehydrogenase following kinetic analysis of the recombinant protein. One important observation was that ripe fruit of A. aconitifolia contained three times the AsA concentration of fruit from tartrate accumulating species. Although not demonstrated through examples, the utility of the gene for manipulating AsA and tartrate levels in plants was protected through an international patent [21] .
The capacity for plant AsA manipulation has now been clearly demonstrated under laboratory conditions however, a number of challenges remain before these findings can be fully commercially exploited. AsA as the main contributor to cellular redox state in plants plays a key role in the perception and transduction of environmental signals [50] and it has yet to be determined how plants with manipulated AsA levels would perform under field conditions. In addition, while GM crops continue to increase in acreage considerable consumer resistance remains in many parts of the World such as Europe and Australasia; therefore either consumers must be convinced of the clear benefits of GM crops with enhanced AsA levels or alternative breeding technologies need to be found.
METABOLIC FLEXIBILITY OF THE YEAST D-ERYTHROASCORBATE PATHWAY -NEW OPPOR-TUNITIES FOR EUKARYOTIC MANUFACTURE OF VITAMIN C
Yeasts do not synthesise AsA but instead produce its 5-carbon analogue D-erythroascorbate (EAsA) through sequential oxidation of the pentose D-arabinose [51] . The enzymes catalysing these reactions lack specificity and are capable of oxidising a range of sugars and their corresponding lactones [52] [53] [54] . In vitro studies showed that the final pathway enzyme, D-aribono-1,4-lactone oxidase (E.C. 1.1.3.37) was capable of oxidising a range of substrates to generate a number of products including EAsA, Lerythroascorbic acid, D-isoascorbic acid, 6-deoxy-L-ascorbic acid and AsA [11] . In vivo studies have additionally shown that AsA can be synthesised by yeasts when provided with an external supply of L-Gal, L-GulL or L-GalL [55] . It therefore appears that the reason yeast cells are unable to synthesise AsA from common substrates is due to metabolic deficiencies with respect to the synthesis of L-Gal. This has led to the development of novel yeast strains in which various approaches have been taken to engineer the synthesis of L-Gal from cheap starting materials.
The discovery that plants synthesise AsA via GDP-DMan and L-Gal represented an opportunity to extend AsA biosynthetic capacity to yeasts by engineering of the appropriate enzymes into suitable yeast strains. Yeasts are capable of the synthesis of GDP-D-Man which acts as a precursor for cell wall components and substrate for protein glycosylation reactions. Therefore, expression of only three enzymes, GDP-D-Man 3,5-epimerase, GDP-L-Gal phosphorylase and L-Gal-1-phosphate phosphatase should be sufficient for the extension of L-Gal synthesis to yeasts. In fact, expression of only GDP-D-Man 3,5-epimerase from Arabidopsis thaliana in Saccharomyces cerevisiae was sufficient for the engineered strain to produce small quantities of AsA [29] . This suggests that yeast cells contain enzyme activities capable of dephosphorylating GDP-L-Gal to free L-Gal. However, further improvements in yield were obtained when the A. thaliana myo-inositol-1-phosphate phosphatase (E.C. 3.1.3.25), catalysing the dephosphorylation of L-Gal-1-phosphate was also expressed; suggesting endogenous dephosphorylating activities were limited. Further yield enhancements were achieved following the expression of a rat GDP-L-fucose pyrophosphorylase (E.C. 2.7.7.30) capable of the conversion of GDP-L-galactose to Lgalactose-1-phosphate [56] . The best strains were those in which heterologous genes encoding A. thaliania L-Gal dehydrogenase and S. cerevisiae D-arabinonolactone oxidase (E.C. 1.1.3.37) were also expressed however, AsA yields were still only 200 μg L -1 . Now that the sequences encoding GDP-L-Gal phosphorylase [57] and L-Gal-1-phosphate phosphatase [58] are available, further strain improvements may be expected.
Although AsA yields from the transgenic yeast strains were too low to represent a viable industrial process, the increased cellular soluble antioxidant content improved the stress resistance of the engineered strains. Strains expressing GDP-D-Man 3,5-epimerase, myo-inositol-1-phosphate phosphatase, L-Gal dehydrogenase and D-arabinonolactone oxidase were highly resistant to H 2 O 2 reaching culture stationary phase in medium containing 2 mM H 2 O 2 within 24 h, a period not significantly different from cells grown in medium without H 2 O 2 . In contrast, wild-type strains which had growth curves indistinguishable from engineered strains in medium lacking H 2 O 2 were completely unable to grow in 2 mM H 2 O 2 [29] . Engineered yeast cells were not only resistant to oxidative stress but also showed enhanced resistance to acid stress, a condition frequently encountered in industrial fermentations. Wild-type cells were almost completely inhibited for growth in medium at pH 2.2 and this inhibition was further enhanced by the addition of 0.5 M lactic acid to the medium. On the contrary, strains engineered to synthesise AsA continued to grow well in acid media supplemented with 0.5 M lactate [56] . Several claims were therefore made for the engineered yeast cells, firstly that they could be used for the industrial synthesis of AsA and secondly that they could be used to increase production, productivity or yield of any other product by virtue of their ability to withstand osmotic, pH, temperature or oxidative stress [29] .
An alternative approach to induce L-Gal synthesis in yeast used bacterial enzymes to convert the readily available substrate L-sorbose. In this application, the broad substrate specificity of bacterial sugar metabolising enzymes was exploited to synthesise L-Gal in a two step pathway. DTagatose epimerase isolated from Pseudomonas sp. is known to use not only D-tagatose but also D-fructose, L-psicose and L-sorbose as substrates [59] . A homologous sequence (AE008210) was cloned from Agrobacterium tumefaciens and the expressed protein was able to convert L-sorbose to Ltagatose in vitro [60] . L-Fucose isomerase (E.C. 5.3.1.25) from Escherichia coli also has broad substrate specificity being capable of the isomerisation of not only L-fucose and L-fuculose but also the structurally similar 5-carbon analogues D-arabinose and D-ribulose [61] . As L-fucose is 6-deoxy-L-Gal, it was postulated that the same enzyme would also be capable of the isomerisation of L-tagatose and L-Gal and a recombinant L-fucose isomerase from E. coli (NC000913) was observed to undertake this reaction in vitro [60] . Co-cultivation of the purified enzymes, S. cerevisiae cells and L-sorbose resulted in the synthesis of AsA via the pathway shown in Fig. (3) [60] however, attempts to synthesise AsA from L-sorbose in yeast cells engineered to express the two enzymes were unsuccessful. One possible explanation is that the low enzyme specificity prevented conversion of the desired substrates as a result of competition for active sites from endogenous metabolites. Future process improvements might include protein engineering to improve enzyme specificity or the development of yeast strains in which pathways producing competing metabolites are blocked.
PATHWAY ENGINEERING IN BACTERIA -EFFICIENT SINGLE STEP PROKARYOTIC MANUFACTURE OF VITAMIN C
Bacterial transformations have been integral to industrial AsA synthesis since the earliest days and a great number of bacterial strains have been used to produce AsA intermediates, frequently in mixed or sequential cultures [11] . Industrial prokaryotes were generally not considered capable of synthesising AsA directly and so strains were engineered for the rapid and efficient production of AsA precursors in single stage fermentations. Many of these developments have been discussed in recent reviews [7, 10, 11, 62] and here the focus will be on the latest developments for the direct single-stage fermentation of AsA in prokaryotic microorganisms.
The genus Gluconobacter and related organisms have been valued in the biotechnology industry for many years. One of the primary features pertaining to their utility is the wide array of both periplasmic and intracellular dehydrogenases which are used in their sugar-rich natural environments (flowers and fruit) for the partial oxidation of sugars and polyols which are then frequently returned to the environment inhibiting the growth of competitor organisms [63] . In industrial AsA synthesis, G. oxydans initially found use within the Reichstein process for the oxidation of Dsorbitol to L-sorbose Fig. (1) and further developments allowed the direct fermentation of 2-keto-L-gulonic acid (2- Fig. (3) . Proposed mechanism of synthesis of AsA using partially purified enzymes and yeast cells. L-Sorbose is sequentially isomerised to L-galactose by the action of recombinant tagatose epimerase (TE, NCBI accession number AE008210) and fucose isomerase (FI, NC000913). L-Galactose is then taken up by intact yeast cells via a sugar transporter ( ) prior to conversion to AsA by the endogenous enzymes arabinose dehydrogenase (AraDH) and arabinonolactone oxidase (AraL Ox). 
KLG); which is transformed to AsA in a single chemical step, from sorbitol [64] . Process efficiency can be reduced through the transport of partially oxidised substrates across the plasma membrane resulting in their channelling into central metabolism via the pentose phosphate pathway Fig.  (4) .
In 1995, it was observed that a particular strain of G. oxydans (later renamed Ketogulonigenium vulgare DSM 4025) [65] commonly used to produce 2-KLG carried an enzyme capable of oxidising L-GulL to AsA [66] . The organism produced AsA yields of approximately 15% from L-GulL in resting cell systems however as a method for the industrial synthesis of AsA was not cost effective due to difficulties in obtaining the reaction substrate. Subsequent analysis of the biosynthetic capacities of the same strain revealed that it was not only capable of AsA synthesis from L-GulL but also from D-sorbitol, L-sorbose and L-sorbosone the substrates usually supplied for the production of 2-KLG [67] . Yields varied with L-sorbosone providing 1.04 g L -1 AsA following 24 h incubation from a 0.5% feedstock, Lsorbose providing 0.87 g L -1 from an 8% feedstock and Dsorbitol providing 90 mg L -1 also from an 8% feedstock. Significant quantities of 2-KLG were also produced when sorbosone was supplied as a substrate however, 2-KLG was not converted to AsA as no AsA synthesis was observed when 2-KLG was supplied. K. vulgare and related genera such as Gluconobacter and Acetobacter contain sorbitol and sorbose dehydrogenases capable of sequentially oxidising Dsorbitol to L-sorbosone [7] . It is well established that they also contain sorbosone dehydrogenases capable of the conversion of L-sorbosone to 2-KLG. The sorbosone dehydrogenases from K. vulgare DSM 4025 were purified and three enzymes capable of the pyrroloquinoline quinine (PQQ) dependent conversion of L-sorbosone directly to AsA were identified following native polyacrylamide gel electrophoresis [68] . All three enzymes were made up of homo-or mixed oligomers of 75 or 55 kDa subunits encoded by full length or truncated expression of the same gene, sndH. The enzymes were also capable of the conversion of L-sorbosone to 2-KLG although the pH optimum for AsA production was lower than that for 2-KLG production at pH 7-8 and greater than pH 8.5, respectively. The use of the nucleotide sequence, purified proteins or recombinant organisms for the production of AsA were protected [69] .
The finding that periplasmic PQQ-dependent L-sorbose dehydrogenases are capable of producing not only 2-KLG but also AsA has led to a great deal of additional research and patent activity primarily by the Dutch company DSM [70, 71] . The main focus has been gene discovery and the improvement of Gluconobacter, Acetobacter and Ketogulonicigenium strains via up-or down-regulation of genes involved in sorbitol/sorbose metabolism (sms genes) or sugar transport systems (sts genes). In addition, the impact of changing expression of genes involved in the synthesis of respiratory chain enzymes or cofactors (rcs genes) or those described as being vitamin C production system (vcs genes) was investigated. The latter included a diverse array of genes encoding enzymes (e.g. GDP-mannose pyrophosphorylase) and regulatory genes (e.g. transcriptional regulatory protein OmpR). Table 1) . Southern probes designed using the G. oxydans DSM 17078 sndH gene hybridised with all of the AsA producing strains 
S/SNDH
AsA + with the exception of the A. aceti strains which also failed to produce products in PCR reactions using primers designed to the DSM 17078 gene ( To further improve process efficiency strain DSM 17078 underwent a series of genetic modifications. Increasing the gene dosage of sndH through the introduction of sndH bearing plasmids into the parental strain almost doubled AsA production in a resting cell assay using 1% L-sorbosone where the parental strain produced 2.5 g L -1 while three independent transformants produced 4.2, 4.2 and 4.1 g L -1 , respectively. Strains transformed with the sndH gene were used to demonstrate the AsA production process at the laboratory scale. Cells were grown in a 1.25 L growth vessel in a medium containing 100 g L -1 sorbitol, yeast extract and salts to reach OD 600nm of 20 after which further medium was pumped into the growth vessel and cell culture transferred to a second vessel containing 5 L of production medium (100 g L -1 sorbitol, 0.3 g L -1 NaCl, 0.12 g L -1
CaSO 4 ) at a rate of 125 mL h -1 . Additional production medium was added to allow continuous harvesting from the production vessel at a rate of 500 mL h -1 which was fed through a crossflow ultrafiltration module with cells returned to the production vessel until an OD 600 nm of 100 was achieved. At this stage, AsA could be harvested from the production vessel at a rate of 2 g h -1 . Further downstream processing included electrodialysis, treatment with chelating, anion and cation exchange resins, removal of impurities with activated carbon and crystallisation producing 98% pure free AsA with an 80% yield in the purification steps [71] .
For maximum conversion efficiency, an entirely periplasmic sorbitol oxidation pathway is desirable Fig. (4) and transfer of reaction intermediates (L-sorbose, L-sorbosone) to the cytoplasm has detrimental effects on product yield therefore efforts were made to isolate and clone genes encoding sugar transporters (sts genes). One of the isolated genes, named sts24, had sequence homology to the P-loop ATPase of phosphotransferase systems. Disruption of the gene in G. oxydans DSM 17078 resulted in improved AsA production from D-sorbitol, L-sorbose or L-sorbosone in resting cell systems with the parental strain producing 145, 212 and 1130 mg L -1 AsA from the respective substrates while the strain carrying the gene disruption produced 1070, 1470 and 3230 mg L -1 AsA, respectively. The relatively higher improvement in AsA production from the former substrates suggests that phosphotransferase systems may be involved in transport of all three substrates across the cytoplasmic membrane into the cell preventing their periplasmic conversion to AsA. Disruption of sts24 was a more effective method for improvement of AsA production than increasing gene dosage of sndH however, combination of both mutations resulted in even higher AsA production Table 2 . A second disruption in the sugar transport system was shown to be effective for improving AsA production. In this case sts01, a D-arabinitol transporter was upregulated by engineering the endogenous gene with a strong constitutive promoter. Strains carrying this mutation in combination with enhanced sndH expression produced 20% more AsA than strains carrying the enhanced sndH expression alone when resting cells were incubated with sorbitol [71] , presumably as a result of improved export of sorbitol or other downstream intermediates from the cytoplasm back to the periplasm.
An alternative to maximising substrate partitioning to the periplasmic space is to downregulate cytoplasmic pathways leading into central metabolism. One major entry point for Lsorbosone into the pentose phosphate pathway is via cytoplasmic sorbosone dehydrogenase Fig. (4) . The gene for a NAD(P)-dependent sorbosone dehydrogenase (sms05) was disrupted in G. oxydans DSM 17078 and the capacity of the Table 2 . In a further series of experiments, gene disruption of sms05 in a background of overexpressing sndH provided further increases in product recovery either from L-sorbosone in resting culture or from D-sorbitol in actively growing culture Table 2 .
As the sorbosone dehydrogenase responsible for AsA synthesis was PQQ-dependent, efforts were made to boost the availability of this cofactor through overexpression of the rcs21 gene, annotated as PQQ biosynthesis protein A. This mutation was reported to increase AsA synthesis from Dsorbitol in a resting cell system by a further 20% when expressed in a background of upregulated sndH [71] , perhaps suggesting cofactor limitation, at least in strains overexpressing sndH.
While the mutations outlined above might perhaps be rationally chosen in a process improvement programme, the improvements conferred from altering expression of the vcs genes are more difficult to predict. Two examples were provided in which genes encoding metabolic enzymes were disrupted. In the first the impact of disrupting a gene encoding mannose-1-phosphate guanyltransferase/ phosphomannose isomerase (vcs01) was shown to have positive impacts on AsA synthesis in G. oxydans DSM 17078 with resting cells carrying the vcs01 disruption producing at least twice as much AsA from D-sorbitol, L-sorbose or Lsorbosone Table 2 . Again, concurrent disruption of vcs01 with overexpression of sndH resulted in even higher product Table 2 . Again, why manipulation of a gene encoding an enzyme involved in primary metabolic pathways would impact on a periplasmic AsA biosynthetic pathway is difficult to imagine.
In the last few years, DSM have filed in excess of 30 patents relating to AsA synthesis in acetobacteria and perhaps the fact that they are the only remaining Western producer of industrial vitamin C is testament to the success of such an aggressive research and development strategy. Their patenting strategy has covered the fermentative production of vitamin C from the D-sorbitol metabolisation pathway, the use of the sndH gene or the protein that it encodes in addition to in excess of 50 genes in the SMS, STS, RCS and VCS systems. The company have also specifically covered the use of a broad range of bacterial genera including Pseudomonas, Pantoea, Escherichia, Corynebacterium, Ketogulonicigenium, Gluconobacter, Acetobacter and Gluconacetobacter.
CURRENT & FUTURE DEVELOPMENTS
Over the last decade several fundamental findings have translated into intellectual property with a very real possibility for their future exploitation. The discovery of the primary AsA biosynthetic pathway in plants as well as several other potential routes to its synthesis has created the opportunity for the development of second generation biotech crops with enhanced nutritional value and potentially improved agronomic performance. Given that several global agbiotech companies such as Syngenta, Monsanto and Dupont are already involved in the commercial development of crops with improved nutritional traits [72] , it seems likely that the high consumer recognition of vitamin C will encourage the development of such crops in the near future.
Market conditions for the industrial synthesis of vitamin C have been difficult over the past decade with exceptionally low prices and flooding of global markets with vitamin C produced in China. Low employment costs and undoubted innovation within the manufacturing plants along with state subsidies have allowed the production of vitamin C within China at costs all but impossible for Western manufacturers to compete with and the result has been that only one vitamin C manufacturing plant remains in the West located in Dalry, Scotland. Perhaps in part as a result of overseas competition, the parent company of the manufacturing plant DSM, have invested heavily in process improvement primarily through single-step bacterial fermentations. Although much of the underlying development work is now in the public domain in the form of international patents, it is difficult to obtain information regarding how far these processes have gone into commercial production.
